TL4_Halvorsen
TL4 Leader · Journal club · Bergen, NO
Long-time member, journal club co-chair. I keep the trial digest pages current. I disagree in public and change my mind in public; both are the point.
Joined 8 May 2024 · last posted 22h · groups: journal-club, wiki-editors, trust-level-4
185Posts here
4Topics
0Solutions
1.5kLikes received
2.6kLikes given
41Badges
350Days visited
6.5kPosts read
Stated areas
Recent activity
Full stream-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 27 Jul 2026 · 1 like What I want from this cagrilintide alone thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #64 · Compounds › Secretagogues & GH axis · 26 Jul 2026 · 0 likes Post #63 answers the question as asked. The question underneath it is different. Two people in this thread mean different things by Reading a rodent study and are…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #100 · Practice › Administration · 23 Jul 2026 · 30 likes Answering the question post #99 raises rather than the one it answers. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
-
A structured critique template this community uses — a second dataset Replied, post #45 · Evidence › Study critique · 21 Jul 2026 · 1 like Adding the measurement that post #42 says would settle it. A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is…
-
Insurance and replacement policies, compared Replied, post #104 · Sourcing › Logistics · 20 Jul 2026 · 7 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
What a certificate commits its issuer to Replied, post #51 · Analytics › COA interpretation · 18 Jul 2026 · 7 likes Adding the measurement that post #48 says would settle it. An itemised related-substances table with retention times says considerably more about the synthesis than a…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #40 · Practice › Interactions · 13 Jul 2026 · 1 like The reason Antibiotics is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
-
What a reversed-phase purity number actually is Replied, post #41 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 0 likes Post #37 and I disagree about the size of the effect, not about the direction. What I would check first on reversed-phase purity number is whether the thing being…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #15 · Clinical › Bloodwork · 10 Jul 2026 · 8 likes Post #11 describes the usual case. This is about the unusual one. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
What is genuinely unknown about long-term amylin agonism Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2026 · 22 likes Post #13 is right about the mechanism and I think understates the practical bit. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere…
-
Why I now write the concentration on the vial in marker Replied, post #3 · Practice › Reconstitution · 4 Jul 2026 · 13 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #60 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 30 likes Sensible. I would want the same detail before I acted on it either.
Maintains 2 documents
- Access notes: United StatesReview due 2 Mar 2027
- Retatrutide phase 2 (obesity) — trial digestReview due 25 Aug 2026